Company Search:
Advanced Search
Sponsored Links
Biomarin Pharmaceutical Inc Company Snapshot
Biomarin Pharmaceutical Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Biomarin Pharmaceutical Inc with three other companies in this sector in the United States: Akorn, Inc. (2015 sales of $985.08 million of which 94% was Prescription Pharmaceuticals), Medivation, Inc. ($943.26 million of which 100% was Medical Technologies), and Impax Laboratories, Inc. ($860.47 million of which 83% was Impax Generics).

Sales Analysis. Biomarin Pharmaceutical Inc reported sales of $889.90 million for the year ending December of 2015. This represents an increase of 18.5% versus 2014, when the company's sales were $751.04 million. Sales at Biomarin Pharmaceutical Inc have increased during each of the previous five years (and since 2010, sales have increased a total of 139%). Sales of Vimizim saw an increase that was more than double the company's growth rate: sales were up 195.1% in 2015, from $77.32 million to $228.15 million. Not all segments of Biomarin Pharmaceutical Inc experienced an increase in sales in 2015: sales of Firdapse fell 11.1% to $16.04 million. (However, this segment's sales were only a very small portion of the company's overall sales). Biomarin Pharmaceutical Inc also experienced decreases in sales in Naglazyme (down 9.4% to $303.09 million) and Aldurazyme (down 7.3% to $97.91 million) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Biomarin Pharmaceutical Inc
  Stock Performance Chart for Biomarin Pharmaceutical Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 86.92
(Figures in U.S. Dollars)
1 Week 0.1%   13 Weeks 1.8%  
4 Weeks 2.2%   52 Weeks 4.5%  
Biomarin Pharmaceutical Inc Key Data:
  Ticker: BMRN Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 889,895,000
(Year Ending Jan 2016).
Employees: 2,158
  Currency: U.S. Dollars Market Cap: 14,949,148,024
  Fiscal Yr Ends: December Shares Outstanding: 171,987,437
  Share Type: Common Closely Held Shares: 847,331
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.